HackerNoon

The 5 AWS Services Every Developer Must Know to Build AI Products in 2026 (With Real Projects)

You don't need to know all 200+ AWS services to build AI products. You need these 5. Here's the complete beginner's guide to ...
Microsoft

Least privilege for AI agents: Identity, access, and tool binding

As AI agents become more autonomous, strong identity, access, and auditing controls are critical to keeping them secure.
The Motley Fool

Recursion Pharmaceuticals vs. Summit Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?

Recursion Pharmaceuticals operates as a TechBio company, using its proprietary Recursion OS to automate biological experiments and analyze them with artificial intelligence. The company generates vast ...
Time

Recursive Self-Improvement is the Human Skill We Need in the AI Age

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
Wall Street Journal

10 of the Best Wealth Management Firms: Well-Known Fiduciary Investment Companies to Consider

WSJ Buy Side is The Wall Street Journal’s research and commerce team. Our commerce content is distinct from our newsroom coverage. We earn a commission from some links in our articles. Learn more. We ...
Scientific American

Anthropic warns AI could soon start improving itself. Critics aren’t convinced

The companies at the frontier of artificial intelligence should be ready to slow down, one of the fastest-moving among them says. Anthropic, the maker of the Claude chatbot, has claimed AI systems may ...
The Next Web

Anthropic says Claude writes 80% of its own code and the world needs a plan to hit the brakes

Anthropic reveals that Claude now writes over 80% of its production code, with engineers shipping 8x more code per quarter than in 2024. The company’s new Anthropic Institute paper maps the path to ...
The Motley Fool

Recursion Pharmaceuticals Just Hit a 52-Week Low. Is This Former Nvidia Holding a Smart Buy Now?

Recursion Pharmaceuticals is trying to solve a serious problem. Even with technological improvements, the time and costs required to develop brand-new drugs have increased in recent decades. It can ...
Crowdfund Insider

AI Startup Recursive Superintelligence Secures $650M

Recursive Superintelligence has raised $650 million at a $4.65 billion valuation in a funding round led by GV and Greycroft, according to the company. The round also included participation from AMD ...
The New York Times

Notable Researchers Join $4 Billion Effort to Build Self-Improving A.I.

Recursive Superintelligence, founded by former Google, Meta and OpenAI researchers, is part of a growing effort to automate the creation of artificial intelligence. By Cade Metz Reporting from San ...
Infosecurity-magazine.com

Researchers Uncover 10 In-the-Wild Prompt Injection Payloads Targeting AI Agents

Security researchers have discovered 10 new indirect prompt injection (IPI) payloads targeting AI agents with malicious instructions designed to achieve financial fraud, data destruction, API key ...